Faculty-Tenure Track, Department of Developmental and Molecular Biology – Bronx, New York
Faculty-Tenure Track, Department of Developmental and Molecular Biology US-NY-Bronx Job ID: 2025-17126 Type: Research # of Openings: 1 Category: F…
Related Articles
Quantifying the shift of public export finance from fossil fuels to renewable energy
Nature Communications – This paper analyzes energy financing patterns of public export credit agencies (ECAs). It demonstrates that mainly European ECAs shifted away from fossil…
Vimeo
Join the web’s most supportive community of creators and get high-quality tools for hosting, sharing, and streaming videos in gorgeous HD with no ads.
Optimal life-cycle adaptation of coastal infrastructure under climate change
Nature Communications – Climate change-related risk mitigation for infrastructure systems often requires adaptation. A computational framework for optimal decision-making under uncertainty based on…
PP01.52 The Effect of Altered RNA Expression on Tumor Immune Infiltration in NSCLC: A Retrospective NGS Study
Molecular testing has identified an increasing number of NSCLC associated genes, but their exact roles are poorly understood. The development of immune checkpoint inhibitors (ICIs)…
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies
Background: The predictive and prognostic role of BRAF alterations has been evaluated in colorectal cancer (CRC); however, BRAF alterations have not been fully characterized in…
Analysis of HER2 Prevalence by RNA Expression Across Solid Tumors – Tempus
Background: The frequency of HER2 expression in solid tumors other than breast (BC) and gastric cancer (GC) is not well defined. This study describes the…
Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy
This cohort study evaluates tumor mutational burden and outcomes in patients with diverse advanced cancers treated with immunotherapy.
132 Racial differences in TMB measures between paired tumor/normal and tumor-only sequencing across endometrial, bladder, and non-small cell lung cancers
Background Tumor mutational burden (TMB), defined as the number of somatic mutations per megabase of a tumor, is routinely used as a predictive biomarker for…
Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
Cancer Immunology, Immunotherapy – Adjuvant immune checkpoint blockade (ICB) following chemoradiotherapy and adding ICB to chemotherapy have been key advances for stages III-IV non-small cell…
Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer
Nature Communications – Some cancer patients with impaired HLA-I still respond to immunotherapy. Here the authors combine a cytotoxic gene signature from CD4+ and CD8+…